Search Results - "Innis, R"

Refine Results
  1. 1

    Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers by Hirvonen, J, Goodwin, R S, Li, C-T, Terry, G E, Zoghbi, S S, Morse, C, Pike, V W, Volkow, N D, Huestis, M A, Innis, R B

    Published in Molecular psychiatry (01-06-2012)
    “…Chronic cannabis (marijuana, hashish) smoking can result in dependence. Rodent studies show reversible downregulation of brain cannabinoid CB 1 (cannabinoid…”
    Get full text
    Journal Article
  2. 2

    Imaging the Function of P‐Glycoprotein With Radiotracers: Pharmacokinetics and In Vivo Applications by Kannan, P, John, C, Zoghbi, S S, Halldin, C, Gottesman, M M, Innis, R B, Hall, M D

    Published in CLINICAL PHARMACOLOGY & THERAPEUTICS (01-10-2009)
    “…P‐glycoprotein (P‐gp), an efflux transporter, controls the pharmacokinetics of various compounds under physiological conditions. P‐gp‐mediated drug efflux has…”
    Get full text
    Journal Article Publication
  3. 3

    Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography by Hirvonen, J, Zanotti-Fregonara, P, Umhau, J C, George, D T, Rallis-Frutos, D, Lyoo, C H, Li, C-T, Hines, C S, Sun, H, Terry, G E, Morse, C, Zoghbi, S S, Pike, V W, Innis, R B, Heilig, M

    Published in Molecular psychiatry (01-08-2013)
    “…Brain cannabinoid CB 1 receptors contribute to alcohol-related behaviors in experimental animals, but their potential role in humans with alcohol dependence is…”
    Get full text
    Journal Article
  4. 4

    cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor by Fujita, M, Richards, E M, Niciu, M J, Ionescu, D F, Zoghbi, S S, Hong, J, Telu, S, Hines, C S, Pike, V W, Zarate, C A, Innis, R B

    Published in Molecular psychiatry (01-05-2017)
    “…Basic studies exploring the importance of the cyclic adenosine monophosphate (cAMP) cascade in major depressive disorder (MDD) have noted that the cAMP cascade…”
    Get full text
    Journal Article
  5. 5

    Two-step ALD process for non-oxide ceramic deposition: the example of boron nitride by Hossain, Ali, Souvignet, Thomas, Innis, Neil R, Hao, Wenjun, Boisron, Olivier, Florea, Ileana, Xiao, Peng, Sledzinska, Marianna, Journet, Catherine, Marichy, Catherine

    Published in JPhys materials (01-07-2024)
    “…Atomic layer deposition (ALD) based on polymer-derived ceramics (PDCs) chemistry is used for the fabrication of boron nitride thin films from reaction between…”
    Get full text
    Journal Article
  6. 6

    [123I]β-CIT SPECT imaging assessment of the rate of Parkinson's disease progression by MAREK, K, INNIS, R, VAN DYCK, C, FUSSELL, B, EARLY, M, EBERLY, S, OAKES, D, SEIBYL, J

    Published in Neurology (11-12-2001)
    “…[123I]beta-CIT and SPECT imaging of the dopamine transporter is a sensitive biomarker of PD onset and severity. In this study, the authors examine the change…”
    Get full text
    Journal Article
  7. 7

    The role of radiotracer imaging in Parkinson disease by RAVINA, B, EIDELBERG, D, GWINN-HARDY, K, MCFARLAND, H, INNIS, R, KATZ, R. G, KIEBURTZ, K, KISH, S. J, LANGE, N, LANGSTON, J. W, MAREK, K, MORIN, L, AHLSKOG, J. E, MOY, C, MURPHY, D, OERTEL, W. H, OLIVER, G, PALESCH, Y, POWERS, W, SEIBYL, J, SETHI, K. D, SHULTS, C. W, SHEEHY, P, ALBIN, R. L, STOESSL, A. J, HOLLOWAY, R, BROOKS, D. J, CARBON, M, DHAWAN, V, FEIGIN, A, FAHN, S, GUTTMAN, M

    Published in Neurology (25-01-2005)
    “…Radiotracer imaging (RTI) of the nigrostriatal dopaminergic system is a widely used but controversial biomarker in Parkinson disease (PD). Here the authors…”
    Get full text
    Journal Article
  8. 8

    Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort by Abi-Dargham, Anissa, Gil, Roberto, Krystal, John, Baldwin, Ronald M., Seibyl, John P., Bowers, Malcom, van Dyck, Christopher H., Charney, Dennis S., Innis, Robert B., Laruelle, Marc

    Published in The American journal of psychiatry (01-06-1998)
    “…OBJECTIVE: The authors previously observed an increase in striatal dopamine transmission following amphetamine challenge in 15 untreated patients with…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene by LARUELLE, M, GELERNTER, J, INNIS, R. B

    Published in Molecular psychiatry (01-05-1998)
    “…Alcoholism and substance abuse have been associated with a polymorphism in a noncoding region of the D2 receptor gene (the A1 allele of the Taq1 'A' system) in…”
    Get full text
    Journal Article
  12. 12

    Prediction of Dopamine Transporter Binding Availability by Genotype: A Preliminary Report by Jacobsen, Leslie K., Staley, Julie K., Zoghbi, Sami S., Seibyl, John P., Kosten, Thomas R., Innis, Robert B., Gelernter, Joel

    Published in The American journal of psychiatry (01-10-2000)
    “…OBJECTIVE: Evidence of a relationship between genotype and binding availability was assessed for the dopamine and serotonin transporter genes. METHOD: The…”
    Get full text
    Journal Article
  13. 13

    Decreased Benzodiazepine Receptor Binding in Prefrontal Cortex in Combat-Related Posttraumatic Stress Disorder by Bremner, J. Douglas, Innis, Robert B., Southwick, Steven M., Staib, Lawrence, Zoghbi, Sami, Charney, Dennis S.

    Published in The American journal of psychiatry (01-07-2000)
    “…OBJECTIVE: Animals exposed to stress exhibit a decrease in benzodiazepine receptor binding in the frontal cortex. No studies have examined central…”
    Get full text
    Journal Article
  14. 14

    [123I]β/CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease by MAREK, K. L, SEIBYL, J. P, ZOGHBI, S. S, ZEA-PONCE, Y, BALDWIN, R. M, FUSSELL, B, CHARNEY, D. S, VAN DYCK, C, HOFFER, P. B, INNIS, R. B

    Published in Neurology (1996)
    “…We have used in vivo single-photon emission computed tomography (SPECT) of the dopamine transporter with 2 beta-carboxymethoxy-3 beta-(4-iodophenyl)tropane…”
    Get full text
    Journal Article
  15. 15
  16. 16

    MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder by Bremner, J D, Randall, P, Scott, T M, Bronen, R A, Seibyl, J P, Southwick, S M, Delaney, R C, McCarthy, G, Charney, D S, Innis, R B

    Published in The American journal of psychiatry (01-07-1995)
    “…Studies in nonhuman primates suggest that high levels of cortisol associated with stress have neurotoxic effects on the hippocampus, a brain structure involved…”
    Get more information
    Journal Article
  17. 17
  18. 18

    Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function by Cropley, Vanessa L., Fujita, Masahiro, Innis, Robert B., Nathan, Pradeep J.

    Published in Biological psychiatry (1969) (15-05-2006)
    “…Molecular imaging with positron emission tomography (PET) and single photon emission computed tomography (SPECT) has recently been used to examine dopamine…”
    Get full text
    Journal Article
  19. 19

    Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients by Anand, Amit, Verhoeff, Paul, Seneca, Nicholas, Zoghbi, Sami S., Seibyl, John P., Charney, Dennis S., Innis, Robert B.

    Published in The American journal of psychiatry (01-07-2000)
    “…OBJECTIVE: Increased dopaminergic neurotransmission has been implicated in the pathophysiology of bipolar disorder. However, it remains unclear whether the…”
    Get full text
    Journal Article
  20. 20